Current Challenges in Cold Chain Procurement

  • March 25th, 2017

It is expected that in the next 5 years 70% of the Pharma / Bio-similar product development, growth is within Cold Chain space. This will proliferate the existing Cold Chain scenario further. Let us hear from a Panel of experts how to manage the current challenges in procurement, storage and shipments. The panel will also talk about regulatory scenario and risk mitigation plans for future

Comments are closed.